- Home
- YMAB vs HUYA Comparison
YMAB vs HUYA Comparison
Compare YMAB & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- HUYA
- Stock Information
- Founded
- YMAB 2015
- HUYA 2014
- Country
- YMAB United States
- HUYA China
- Employees
- YMAB N/A
- HUYA N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- HUYA Computer Software: Programming Data Processing
- Sector
- YMAB Health Care
- HUYA Technology
- Exchange
- YMAB Nasdaq
- HUYA Nasdaq
- Market Cap
- YMAB 631.1M
- HUYA 728.9M
- IPO Year
- YMAB 2018
- HUYA 2018
- Fundamental
- Price
- YMAB $11.14
- HUYA $3.07
- Analyst Decision
- YMAB Strong Buy
- HUYA Buy
- Analyst Count
- YMAB 8
- HUYA 4
- Target Price
- YMAB $21.38
- HUYA $5.68
- AVG Volume (30 Days)
- YMAB 268.9K
- HUYA 1.9M
- Earning Date
- YMAB 11-08-2024
- HUYA 11-12-2024
- Dividend Yield
- YMAB N/A
- HUYA N/A
- EPS Growth
- YMAB N/A
- HUYA N/A
- EPS
- YMAB N/A
- HUYA N/A
- Revenue
- YMAB $84,553,000.00
- HUYA $871,494,902.00
- Revenue This Year
- YMAB $10.24
- HUYA N/A
- Revenue Next Year
- YMAB $20.21
- HUYA $7.23
- P/E Ratio
- YMAB N/A
- HUYA N/A
- Revenue Growth
- YMAB N/A
- HUYA N/A
- 52 Week Low
- YMAB $5.17
- HUYA $2.93
- 52 Week High
- YMAB $20.90
- HUYA $6.84
- Technical
- Relative Strength Index (RSI)
- YMAB 25.01
- HUYA 32.78
- Support Level
- YMAB $12.47
- HUYA $3.10
- Resistance Level
- YMAB $15.69
- HUYA $3.27
- Average True Range (ATR)
- YMAB 0.97
- HUYA 0.16
- MACD
- YMAB -0.46
- HUYA -0.00
- Stochastic Oscillator
- YMAB 9.88
- HUYA 7.22
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About HUYA HUYA Inc. American depositary shares each representing one ordinary share
Established in 2011, Huya is the largest online game livestreaming company in China. Headquartered in Guangzhou, Huya mainly provides livestreamed videos on esports games such as League of Legends and Honor of Kings and collects virtual tips from viewers. Its products include the Huya Live platform in China and Nimo TV in Southeast Asia and South America. As of 2023, Huya was a subsidiary of Tencent, which owned 63% of its equity stake and held 94% of the voting power.